Inhibition of α-Synuclein Amyloid Fibril Elongation by Blocking Fibril Ends.

作者: Volodymyr V Shvadchak , Kseniia Afitska , Dmytro A Yushchenko , None

DOI: 10.1002/ANIE.201801071

关键词:

摘要: Misfolding of the protein α-synuclein (αSyn) into amyloid fibrils plays a central role in development Parkinson's disease. Most approaches for inhibition αSyn fibril formation are based on stabilizing native monomeric form or destabilizing fibrillized misfolded form. They require high concentrations inhibitor and therefore cannot be easily used therapies. In this work, we designed an (Inh-β) that selectively binds growing ends creates steric hindrance binding αSyn. This approach permits at Inh-β (IC50 =850 nm) much lower than concentration We studied its kinetic mechanism in vitro identified reactions limit efficiency. It is shown blocking effective to inhibiting growth provides insights inhibitors aggregation.

参考文章(38)
Pauline Wales, Raquel Pinho, Diana F. Lázaro, Tiago F. Outeiro, Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration. Journal of Parkinson's disease. ,vol. 3, pp. 415- 459 ,(2013) , 10.3233/JPD-130216
Andreas A. Deeg, Anne M. Reiner, Felix Schmidt, Florian Schueder, Sergey Ryazanov, Viktoria C. Ruf, Karin Giller, Stefan Becker, Andrei Leonov, Christian Griesinger, Armin Giese, Wolfgang Zinth, Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to α-synuclein aggregates Biochimica et Biophysica Acta (BBA) - General Subjects. ,vol. 1850, pp. 1884- 1890 ,(2015) , 10.1016/J.BBAGEN.2015.05.021
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O’Brien, John Q Trojanowski, Virginia M-Y Lee, Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice Science. ,vol. 338, pp. 949- 953 ,(2012) , 10.1126/SCIENCE.1227157
Tuomas P. J. Knowles, Michele Vendruscolo, Christopher M. Dobson, The amyloid state and its association with protein misfolding diseases Nature Reviews Molecular Cell Biology. ,vol. 15, pp. 384- 396 ,(2014) , 10.1038/NRM3810
Ritwik Burai, Nadine Ait-Bouziad, Anass Chiki, Hilal A. Lashuel, Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis. Journal of the American Chemical Society. ,vol. 137, pp. 5041- 5052 ,(2015) , 10.1021/JA5131726
Hilal A. Lashuel, Cassia R. Overk, Abid Oueslati, Eliezer Masliah, The many faces of α-synuclein: from structure and toxicity to therapeutic target Nature Reviews Neuroscience. ,vol. 14, pp. 38- 48 ,(2013) , 10.1038/NRN3406
Dorothea Pinotsi, Alexander K. Buell, Celine Galvagnion, Christopher M. Dobson, Gabriele S. Kaminski Schierle, Clemens F. Kaminski, Direct Observation of Heterogeneous Amyloid Fibril Growth Kinetics via Two-Color Super-Resolution Microscopy Nano Letters. ,vol. 14, pp. 339- 345 ,(2014) , 10.1021/NL4041093
Dmytro A. Yushchenko, Jonathan A. Fauerbach, Shyamala Thirunavukkuarasu, Elizabeth A. Jares-Erijman, Thomas M. Jovin, Fluorescent Ratiometric MFC Probe Sensitive to Early Stages of α-Synuclein Aggregation Journal of the American Chemical Society. ,vol. 132, pp. 7860- 7861 ,(2010) , 10.1021/JA102838N
K MAGUIREZEISS, α-Synuclein: A therapeutic target for Parkinson’s disease? Pharmacological Research. ,vol. 58, pp. 271- 280 ,(2008) , 10.1016/J.PHRS.2008.09.006